Drug intelligence / Profile preview

3M Clinpro Fluoride Aqueous Solution

Development stage: Preclinical
Lead developer: Solventum US LLC
Administration: Topical

Overview

3M Clinpro Fluoride Aqueous Solution, also known as Clinpro Clear Fluoride Treatment, is a water-based, rosin-free medical device containing 2.1% sodium fluoride and stabilized calcium phosphate. Developed by Solventum US LLC, it is designed for the topical treatment of dentin hypersensitivity. Its mechanism involves promoting the remineralization of enamel and dentin and occluding dentinal tubules to reduce sensitivity.

Brand names: ClinproClinpro Clear Fluoride TreatmentClinpro In Office 2.1% NaF Clear Fluoride Treatment
Other names: 2.1% Sodium Fluoride Aqueous Solution

Beyond the preview

Go deeper on 3M Clinpro Fluoride Aqueous Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3M Clinpro Fluoride Aqueous Solution.

Explore the full profile